NPPA and hypertensive disorder: In an animal model of hypertension, M-atrial natriuretic peptide (M-ANP) has been demonstrated to reduce BP (9), and another study identified that in rural Chinese patients with EH, ANP Val7Met polymorphism may be a genetic marker for baseline diastolic BP (DBP) (10).